AU2002214189A1 - Methods of identifying inhibitory compounds and uses thereof - Google Patents
Methods of identifying inhibitory compounds and uses thereofInfo
- Publication number
- AU2002214189A1 AU2002214189A1 AU2002214189A AU1418902A AU2002214189A1 AU 2002214189 A1 AU2002214189 A1 AU 2002214189A1 AU 2002214189 A AU2002214189 A AU 2002214189A AU 1418902 A AU1418902 A AU 1418902A AU 2002214189 A1 AU2002214189 A1 AU 2002214189A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- inhibitory compounds
- identifying inhibitory
- identifying
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/02—Food
- G01N33/04—Dairy products
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23402100P | 2000-09-20 | 2000-09-20 | |
US60/234,021 | 2000-09-20 | ||
US09/956,522 | 2001-09-19 | ||
US09/956,522 US20020128203A1 (en) | 2000-09-20 | 2001-09-19 | Methods of identifying inhibitory compounds and uses thereof |
PCT/IB2001/002120 WO2002024177A2 (en) | 2000-09-20 | 2001-09-20 | Methods of identifying inhibitory compounds and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002214189A1 true AU2002214189A1 (en) | 2002-04-02 |
Family
ID=26927474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002214189A Abandoned AU2002214189A1 (en) | 2000-09-20 | 2001-09-20 | Methods of identifying inhibitory compounds and uses thereof |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020128203A1 (en) |
AU (1) | AU2002214189A1 (en) |
WO (1) | WO2002024177A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4969002B2 (en) * | 1999-06-08 | 2012-07-04 | ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン | Compounds and methods for increasing rAAV transduction |
US7241447B1 (en) * | 1999-10-07 | 2007-07-10 | University Of Iowa Research Foundation | Adeno-associated virus vectors and uses thereof |
US10078087B2 (en) | 2001-05-01 | 2018-09-18 | Senomyx, Inc. | Assays and enhancers of the human delta ENaC sodium channel |
EP1608763A2 (en) * | 2003-03-31 | 2005-12-28 | University Of Iowa Research Foundation | Compounds and methods to enhance raav transduction |
JP2007528712A (en) * | 2003-07-10 | 2007-10-18 | セノミックス、インコーポレイテッド | Use of phenamyl to improve the efficacy of ENaC synergists in improved electrophysiological assays using human ENaC expressing oocytes and assays using membrane potential reporter dyes |
SE0402832D0 (en) * | 2004-11-18 | 2004-11-18 | Astrazeneca Ab | Methods |
AU2007243184A1 (en) * | 2006-04-28 | 2007-11-08 | University Of Iowa Research Foundation | Methods and compounds to modulate parvovirus transduction of mammalian cells or to alter virus infection, method to identify a viral receptor or co-receptor |
US11702672B2 (en) | 2016-02-08 | 2023-07-18 | University Of Iowa Research Foundation | Methods to produce chimeric adeno-associated virus/bocavirus parvovirus |
EP3426787A1 (en) | 2016-03-07 | 2019-01-16 | University of Iowa Research Foundation | Aav-mediated expression using a synthetic promoter and enhancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234922A (en) * | 1992-09-28 | 1993-08-10 | University Of Iowa Research Foundation | Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea |
US5780242A (en) * | 1993-06-18 | 1998-07-14 | Nickel; Alfred A. | Bioassay for the screening of ION channel active molecules |
US5437982A (en) * | 1993-09-08 | 1995-08-01 | University Of Washington | Methods of identifying specific inactivation gate inhibitors of the sodium channel |
US5693756A (en) * | 1994-02-28 | 1997-12-02 | The Johns Hopkins University | Amiloride-sensitive sodium channel and method of identifying substances which stimulate or block salty taste perception |
US5892018A (en) * | 1996-04-02 | 1999-04-06 | Welsh; Michael J. | DNA sequences encoding a brain sodium channel protein |
ES2225979T3 (en) * | 1996-07-22 | 2005-03-16 | Daiichi Suntory Pharma Co., Ltd. | DERIVATIVES OF ARILPIPERIDINOL AND ARILPIPERIDINE AND PHARMACOS CONTAINING THEM. |
US6551775B1 (en) * | 1997-03-11 | 2003-04-22 | Yale University | Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
DE19907385A1 (en) * | 1999-02-20 | 2000-08-24 | Boehringer Ingelheim Pharma | New 3-(phenoxy or phenylalkoxy)-2-phenyl-propylamines, useful for treating e.g. arrhythmia, spasms, pain or neurodegenerative diseases, are tension-dependent sodium channel blockers |
-
2001
- 2001-09-19 US US09/956,522 patent/US20020128203A1/en not_active Abandoned
- 2001-09-20 AU AU2002214189A patent/AU2002214189A1/en not_active Abandoned
- 2001-09-20 WO PCT/IB2001/002120 patent/WO2002024177A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20020128203A1 (en) | 2002-09-12 |
WO2002024177A3 (en) | 2003-03-13 |
WO2002024177A2 (en) | 2002-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003299509A1 (en) | Crosslinked compounds and methods of making and using thereof | |
AU2003217870A1 (en) | Pini-modulating compounds and methods of use thereof | |
AU2003225668A1 (en) | Pin1-modulating compounds and methods of use thereof | |
AU2003225669A1 (en) | Pin1-modulating compounds and methods of use thereof | |
AU2002324775A1 (en) | Architecture tool and methods of use | |
AU2003213673A1 (en) | Pin1-modulating compounds and methods of use thereof | |
AU2001280599A1 (en) | Compounds and methods | |
AU2002314466A1 (en) | Withasol and methods of use | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
AU2001253418A1 (en) | Compounds and methods | |
AU2002216649A1 (en) | Benzoxazole lpaat- beta inhibitors and uses thereof | |
AU2001243394A1 (en) | Compounds and methods | |
AU2001259817A1 (en) | Methods of and compounds for inhibiting calpains | |
AU2001267428A1 (en) | Direct detection of individual molecules | |
AU2002337913A1 (en) | Glycosulfopeptide inhibitors and methods of use thereof | |
AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
AU2002211370A1 (en) | Inhibition of tgf-beta and uses thereof | |
AU2002219900A1 (en) | Minimal identification of features | |
AU2001273052A1 (en) | Antifungal compounds and methods of use | |
AU2002214189A1 (en) | Methods of identifying inhibitory compounds and uses thereof | |
AU2002359694A1 (en) | Compounds and methods | |
AU2001261676A1 (en) | Method and reagent for the inhibition of erg | |
AUPQ872300A0 (en) | Compounds and methods | |
AU2001259448A1 (en) | Fluorous tagging compounds and methods of increasing the fluorous nature of compounds | |
AU2002363938A1 (en) | Methods and use of motoneuronotropic factors |